(19)
(11) EP 0 968 206 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
24.01.2007 Bulletin 2007/04

(45) Mention of the grant of the patent:
15.11.2006 Bulletin 2006/46

(21) Application number: 98906555.2

(22) Date of filing: 19.02.1998
(51) International Patent Classification (IPC): 
C07D 403/04(2006.01)
C07D 401/14(2006.01)
C07D 405/14(2006.01)
C07D 417/14(2006.01)
 C07D 403/14(2006.01)
C07D 409/14(2006.01)
C07D 413/14(2006.01)
A61K 31/505(2006.01)
(86) International application number:
PCT/US1998/003176
(87) International publication number:
WO 1998/037079 (27.08.1998 Gazette 1998/34)

(54)

N-HETEROCYCLIC DERIVATIVES AS NOS INHIBITORS

N-HETEROCYCLISCHE DERIVATE ALS NOS INHIBITOREN

DERIVES N-HETEROCYCLIQUES UTILES EN TANT QU'INHIBITEURS DE LA NO SYNTHETASE

(84) Designated Contracting States:
AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

(30) Priority: 19.02.1997 US 808975
17.02.1998 US 25124

(43) Date of publication of application:
05.01.2000 Bulletin 2000/01

(60) Divisional application:
06023449.9

(73) Proprietors:
  • Berlex, Inc.
    Richmond, CA 94804-0099 (US)
  • PHARMACOPEIA, INC.
    Princeton, NJ 08540 (US)

(72) Inventors:
  • ARNAIZ, Damian, O.
    Hercules, CA 94547 (US)
  • BALDWIN, John, J.
    Gwynedd Valley, PA 19437 (US)
  • DAVEY, David, D.
    El Sobrante, CA 94803 (US)
  • DEVLIN, James, J.
    Lafayette, CA 94549 (US)
  • DOLLE, Roland, Ellwood, III
    King of Prussia, PA 19460 (US)
  • ERICKSON, Shawn, David
    New York, NY 10040 (US)
  • McMILLAN, Kirk
    Trenton, NJ 08618 (US)
  • MORRISSEY, Michael, M.
    Danville, CA 94506 (US)
  • OHLMEYER, Michael, H., J.
    Plainsboro, NJ 08536 (US)
  • PAN, Gonghua
    Plainsboro, NJ 08536 (US)
  • PARADKAR, Vidyadhar, Madhav
    Somerville, NJ 08876 (US)
  • PARKINSON, John
    Martinez, CA 94553 (US)
  • PHILLIPS, Gary, B.
    Pleasant Hill, CA 94523 (US)
  • YE, Bin
    Richmond, CA 94806 (US)
  • ZHAO, Zuchun
    El Sobrante, CA 94803 (US)

(74) Representative: Pohlman, Sandra M. et al
Dörries Frank-Molnia & Pohlman, Triftstrasse 13
80538 München
80538 München (DE)


(56) References cited: : 
EP-A- 0 257 850
   
  • L DEL CORONA ET AL.: "Synthesis and in vitro study of platelet antiaggregant activity of 2(4)-imidazol-1-yl-4(2)-cycloalkylaminopyr imidines" EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, vol. 26, no. 7, 1991, PARIS FR, pages 729-733, XP002064599
 
Remarks:
The file contains technical information submitted after the application was filed and not included in this specification
 
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).